The Human FOLH1 (Folate Hydrolase 1) gene is responsible for the hydrolysis of folates, which are essential for the synthesis of nucleic acids and the metabolism of amino acids. FOLH1 plays a crucial role in the regulation of the folate cycle, and its dysregulation has been implicated in various diseases, including cancer. The gene is expressed in a variety of tissues, with particularly high levels in the liver, where it contributes to the detoxification of excess folates.
From a cellular perspective, the HEK293T cell line, a derivative of the original HEK293 cells, has been engineered to stably express the human FOLH1 gene. This stable cell line serves as an invaluable tool for studying the function of FOLH1 in a controlled environment. Researchers can use this cell line to investigate the effects of FOLH1 on cellular processes, such as DNA synthesis and repair, as well as its potential role in disease pathogenesis. The HEK293T background provides a robust platform for protein expression and allows for the examination of FOLH1's enzymatic activity and its interactions with other cellular components.
Four new murine monoclonal antibodies (mAbs) that target FOLH1, a verified marker in prostate cancer, were described by the researchers. A variety of in vitro tests, including as Western blotting, immunofluorescence, immunohistochemistry, ELISA, flow cytometry, and surface plasmon resonance, were used to assess the mAbs. They evaluated the effectiveness of mAbs for in vivo applications using a mouse xenograft model. The findings show that all mAbs for FOLH1 have a high level of specificity, with 1A11 and 3F11 binding linear epitopes and 5D3 and 5B1 identifying unique conformational epitopes. Interestingly, 5D3 outperformed J591 in terms of affinity (0.14 nM by ELISA, 1.2 nM by flow cytometry), indicating that it may be used in more advanced theranostic development that targets FOLH1.
Figure 1. The researchers achieved stable overexpression of human FOLH1 (also known as PSMA) in HEK293T/17 cells via transfection with pcDNA4/V5-His A vector carrying FOLH1 cDNA. Peptide scanning was used by the researchers to demonstrate FOLH1 epitope identification across species. Using ortholog/paralog samples and human PSMA-overexpressing HEK293T/17 lysates, they further confirmed with mAb Western blotting. (Nováková Z, et al., 2017)
The Human FOLH1 Stable Cell Line - HEK293T is a cell line that has been genetically engineered to express the FOLH1 gene, which encodes for folylpolyglutamate synthase. This enzyme is involved in the synthesis of folates, which are essential for DNA synthesis and repair. The applications of this cell line are diverse and include:
(1) Drug Development: Researchers can use this cell line to screen for compounds that modulate FOLH1 activity, potentially leading to the development of new drugs for diseases associated with folate metabolism, such as cancer and anemia.
(2) Gene Function Studies: The stable expression of FOLH1 allows for the investigation of the gene's role in cellular processes, including its impact on cell proliferation and differentiation. This can provide insights into the molecular mechanisms underlying various cellular functions.
(3) Disease Modeling: By manipulating FOLH1 expression, scientists can create models to study diseases related to folate metabolism, such as neural tube defects and certain genetic disorders. This can help in understanding disease pathogenesis and developing targeted therapies.
Customer Q&As
How does the Human FOLH1 Stable Cell Line - HEK293T provide a unique research platform for studying folate metabolism?
A: The Human FOLH1 Stable Cell Line - HEK293T, by stably expressing human folylpolyglutamate synthase (FOLH1), offers an ideal model for studying the folate metabolic pathway. This cell line allows scientists to directly observe FOLH1 activity at the cellular level and its impact on folate metabolism. By manipulating FOLH1 expression levels, researchers can explore the link between folate metabolism abnormalities and diseases such as cancer, as well as develop therapeutic strategies targeting the folate metabolic pathway.
How does the Human FOLH1 Stable Cell Line - HEK293T assist in drug development for screening therapeutic agents targeting folate-dependent tumors?
A: In drug development, the Human FOLH1 Stable Cell Line - HEK293T can serve as a screening platform to identify and validate compounds that inhibit the growth of folate-dependent tumors. By testing compounds in these cells, researchers can evaluate their effects on FOLH1 activity, thereby screening for potential anticancer drug candidates. This approach helps accelerate the development of novel anticancer therapies targeting the folate metabolic pathway.
What role does the Human FOLH1 Stable Cell Line - HEK293T play in studying the molecular mechanisms of folate deficiency?
A: The Human FOLH1 Stable Cell Line - HEK293T contributes to the study of the molecular mechanisms of folate deficiency by simulating a cellular environment where folate is lacking. This cell line can be used to investigate how folate deficiency affects cellular functions and metabolic disorders, as well as how these disorders impact cell growth, differentiation, and apoptosis. This is crucial for understanding the pathophysiology of folate deficiency and developing preventive strategies.
What is the application of the Human FOLH1 Stable Cell Line - HEK293T in bioavailability studies of folate supplements?
A: The Human FOLH1 Stable Cell Line - HEK293T can be used to evaluate the bioavailability of different folate supplements by monitoring changes in intracellular folate levels. This cell line assists researchers in understanding the conversion and utilization efficiency of various folate forms within cells, providing a scientific basis for the development of more effective folate supplements.
What is the importance of the Human FOLH1 Stable Cell Line - HEK293T in studying the relationship between folate and neural development?
A: Folate plays a crucial role in neural development, especially during embryonic stages. The Human FOLH1 Stable Cell Line - HEK293T can simulate the environment of neural cells to study how folate affects the growth and development of neural cells. This is significant for uncovering the link between folate deficiency and neural developmental abnormalities, as well as developing strategies to prevent neural developmental disorders.
Ask a Question
Customer Reviews
High Expression Efficiency
The Human FOLH1 Stable Cell Line - HEK293T can efficiently and stably express the FOLH1 gene, facilitating its functional study.
Easy Maintenance
This cell line grows rapidly and is easy to cultivate and maintain under laboratory conditions.
Wide Application
Suitable for various biological research, including drug screening and gene function analysis.
Good Transfection Efficiency
HEK293T cells are sensitive to multiple transfection methods, facilitating gene manipulation.
Write a Review